These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11253161)

  • 41. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
    Castaño G; Fernández L; Mas R; Illnait J; Mesa M; Fernández JC
    Clin Drug Investig; 2003; 23(10):639-50. PubMed ID: 17535079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholesterol-lowering effects of policosanol in rabbits.
    Arruzazabala ML; Carbajal D; Mas R; Molina V; Valdes S; Laguna A
    Biol Res; 1994; 27(3-4):205-8. PubMed ID: 8728832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pharmacological surveillance study of the tolerability of policosanol in the elderly population.
    Fernández S; Más R; Gamez R; Diaz A; Fernández J; Deibis Orta S; Illnait J; Castańo G; Mendoza S; Valdés F; Alvarez E
    Am J Geriatr Pharmacother; 2004 Dec; 2(4):219-29. PubMed ID: 15903280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
    Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G
    Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
    Davidson MH; Donovan JM; Misir S; Jones MR
    Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Ballantyne CM; Shah S; Kher U; Hunter JA; Gill GG; Cressman MD; Ashraf TB; Johnson-Levonas AO; Mitchel YB
    Am J Cardiol; 2017 Feb; 119(3):388-396. PubMed ID: 27956003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia.
    Arruzazabala ML; Noa M; Menéndez R; Más R; Carbajal D; Valdés S; Molina V
    Braz J Med Biol Res; 2000 Jul; 33(7):835-40. PubMed ID: 10881060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study.
    Cho KH; Kim SJ; Yadav D; Kim JY; Kim JR
    Oxid Med Cell Longev; 2018; 2018():4809525. PubMed ID: 29854085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
    Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
    Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study.
    Batista J; Stüsser R; Saéz F; Pérez B
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):134-7. PubMed ID: 8705091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.
    Menéndez R; Más R; Amor AM; González RM; Fernández JC; Rodeiro I; Zayas M; Jiménez S
    Br J Clin Pharmacol; 2000 Sep; 50(3):255-62. PubMed ID: 10971310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.
    Barrat E; Zaïr Y; Ogier N; Housez B; Vergara C; Maudet C; Lescuyer JF; Bard JM; Carpentier YA; Cazaubiel M; Peltier SL
    Int J Food Sci Nutr; 2013 Nov; 64(7):882-9. PubMed ID: 23815518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial.
    Amarenco P; Goldstein LB; Messig M; O'Neill BJ; Callahan A; Sillesen H; Hennerici MG; Zivin JA; Welch KM;
    Stroke; 2009 Jul; 40(7):2486-92. PubMed ID: 19461031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study.
    Castaño G; Más R; Fernández L; Gámez R; Illnait J
    Angiology; 2003 Jan; 54(1):25-38. PubMed ID: 12593493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study.
    Wang HY; Jiao QP; Chen SY; Sheng J; Jiang H; Lu J; Zheng SB; Fang NY
    Am J Med Sci; 2018 Sep; 356(3):254-261. PubMed ID: 30286820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters.
    Kassis AN; Marinangeli CP; Jain D; Ebine N; Jones PJ
    Atherosclerosis; 2007 Sep; 194(1):153-8. PubMed ID: 17123537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.